Patient Screening Completed in Cystic Fibrosis Phase 2 SPAN Clinical Trial
Patient screening in the ongoing phase 2 SPAN clinical trial researching a new enteric microgranulation formulation of adrulipase for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis (CF) has been completed, First Wave BioPharma announced. “We plan to announce the completion of patient enrollment shortly and remain on track to report topline…